Teduglutide
Gattex · Revestive · ALX-0600
A GLP-2 analog approved for short bowel syndrome in patients dependent on parenteral support. GLP-2 acts on the intestinal mucosa, a different receptor from the GLP-1 agonists used for metabolic indications.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
~2 h in healthy subjects, ~1.3 h in short bowel syndrome, subcutaneous. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied as a lyophilized powder in a single-dose vial, reconstituted with the supplied diluent before use.
References
- FDA label: Gattex (NDA 203441)
Read the source
Related in Healing / Recovery
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.